April 11, 2016

AbbVie’s Venclexta received priority review, accelerated approval and the breakthrough therapy designation from the FDA. 

April 8, 2016

With the new name, Asembia plans to continue expanding on its specialty pharmaceutical offerings, including solutions for pharmacies, pharmaceutical and biotech companies and payers.

April 6, 2016

The combined company would bring to market oncology therapies, men’s and women’s health therapeutics and consumer health products. 

April 6, 2016

Hospira, now a Pfizer company, entered into an agreement with Celltrion and Celltrion Healthcare in 2009 for several potential biosimilar products, including the recently-approved Inflectra.

April 5, 2016

The accreditation program evaluated CVS Specialty based on such organizational standards as pharmacy care, pharmacy operations and specialty drug and patient management, as well as   the company’s customer service, communications and disclosure standards. 

April 5, 2016
Diplomat will be dispensing Eli Lilly and Co.’s recently approved plaque psoriasis treatment as part of a limited-distribution network. 
April 5, 2016

The partnership is aimed at accelerating several of CutisPharma's products in development toward FDA approval. 

April 5, 2016

Descovy has a similar antiviral efficacy to Gilead’s Viread (tenofovir disoproxil fumarate), but contains one-tenth the dose of tenofovir as Viread, the company said. 

April 4, 2016

Nimbus Apollo’s development program includes a lead candidate for an ACC inhibitor to treat the liver disease non-alcoholic steatohepatitis (NASH), which affects up to 15 million people in the U.S.

April 4, 2016

McKesson has closed its $1.2 billion acquisitions of Biologics and Vantage Oncology, which the company had announced in February. 

March 31, 2016
The FDA granted priority review status to Defitelio and it received an orphan drug designation. The injectable drug’s distribution is expected to being within a week. 
March 29, 2016

By 2020, the biosimilars market will grow to $390 billion and the patents on eight biologic drugs will expire.

March 28, 2016

The fifth edition of this special Rx-Impact report — inserted in headquarter copies of this issue of DSN and delivered to all current members of the U.S. House of Representatives and Senate — is meant to help educate lawmakers on the important role community pharmacy plays as the face of health care in neighborhoods all across America, helping to lower the cost of health care, improving patient access, advancing the quality of care and ultimately delivering better outcomes.

March 25, 2016

With the ability to share information with healthcare practitioners or family members, CareKit apps help people take a more active role in their health.

March 23, 2016

Taltz uses an antibody to bind to an inflammation-causing protein, inhibiting the inflammatory response that can contribute to plaque psoriasis development. 

March 21, 2016

The drug launch marks the first product Teligent is rolling out from its portfolio of withdrawn and discontinued drug applications that the company acquired from AstraZeneca in 2014. 

March 17, 2016

As new blood cancer therapies come to market and patients are able to manage their disease with oral medications at home, Walgreens Specialty Pharmacy pharmacists are well-positioned on the front lines.

March 15, 2016
The average price for branded drugs rose 16.2% in 2015, with a third of branded product seeing a price hike last year, according to Express Scripts. 
March 15, 2016

Like a powerful tide that gradually eats away at the foundations of a once-impregnable sea wall, the booming market for generic drugs advances and recedes with the rise and fall in the number of branded drug patent expirations each year. Download the full Generic Drug Report 2016 to read more.

March 11, 2016

As many as 88% of pharmacists provide medication management services, according to APhA's  2016 edition of the APhA Pharmacists’ Patient Care Services Digest. 

March 11, 2016

Benzer Pharmacy is opening a new location in Louisiana — a specialty hub that marks the company's third location in the state.

March 9, 2016

FLINT, Mich. — Diplomat pharmacy, in honor of Multiple Sclerosis Awareness Week, has rolled out a new campaign featuring patients living with MS. As part of the campaign, the company released a video of one MS patients, highlighting the story of one of the 350,000 to 500,000 people diagnosed with MS. 

March 9, 2016

Lupin said the acquisition will grow the company’s footprint in the U.S. generics market and expands its dermatology, controlled substance product and high value and niche generics pipeline

March 7, 2016

The drug is indicated as a routine prophylactic treatment to prevent and reduce frequency of bleeding episodes, as an on-demand bleeding control and prevention and as a perioperative management for bleeding.